HEALTH

Top external analgesics show positive dollar sales

BY DSN STAFF

In the external analgesic category multi-outlet channel, private label experienced the highest percent of units sold on promotion (24%). (Figure 1) Among national brands, Salonpas displayed the highest percent of units sold on promotion (22%). Icy Hot experienced the largest annual gross sales ($116 million) followed by Salonpas and private label across all outlets. Most of the top brands in this segment showed a positive percent change in dollar sales compared with the prior year. However, private label and Bengay showed reduced retail sales by 4% and 5% respectively.

To view the full report with additional charts, click here.

In the drug class of trade, private label ranked second in retail sales reflecting $32 million, while Salonpas ranked third with $27 million in retail sales for the past 52 weeks.

CPR average retailer margins by channel demonstrates that Salonpas has the highest average retailer margins in the food (42%) and drug (49%) channels. These margins are above average for the external analgesic-rubs segment, margins that reflect 38% and 43% for the food and drug channels, respectively. CPR’s Retailer Margin Report indicates that among the various segments in the internal pain category, the anti-itch segment has higher retailer margin percentages — mass (36%), food (40%) and drug (51%) — compared with category average margin percentages — mass (34%), food (39%) and drug (44%). In the internal analgesic category, feminine pain relief has greater overall average retailer margin in all channels. In contrast, general pain relief experienced lower average retailer margin compared with category averages. (Figure 2)

According to ECRM, circular ad counts for the internal analgesics segment are far greater than circular ads offered by the external analgesics segment. Private label offered the highest number of ads (667), while Bayer offered the least (17). In comparison, in the external rubs segment, private label offered the highest number of ads (90) while Bengay offered the fewest ads with only 23 circular ads.

DSN has partnered with Competitive Promotion Report (CPR) and IRI to create a series of exclusive reports. This article highlights the market performance of major brands in the pain category for both the internal and external analgesic segments. The time period covered for this article is the past 24 months ended June 14, 2015. This analysis was gathered using growth in retail sales, CPR average retailer margin percentages, and retailer ads in the analgesics category.

CPR is a leading provider of competitive market intelligence and insights in the health, beauty and wellness industry. Learn more by visiting competitivepromotion.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Social media maven joins CHPA’s Five Moms campaign

BY Michael Johnsen

WASHINGTON — The Consumer Healthcare Products Association on Wednesday announced LeeAnn Weniger-Mandrillo as the newest mom to join its Five Moms campaign — an initiative to raise parental awareness of teen cough medicine abuse. 
 
“The issue of teen medicine abuse is particularly important to me, as I have focused my career on my community activism through work with the Prevention Council of Saratoga County, the New York State PTA, New York Office of Alcoholism and Substance Abuse Services and the Paterson Coalition against Substance Abuse,” Weniger-Mandrillo said. “I firmly believe that spreading the word about the dangers of teen medicine abuse can help reduce abuse rates and keep teens safe and healthy. As one of the Five Moms, I am excited to have an additional platform to reach families nationwide and raise awareness of cough medicine abuse.”
 
“We are excited to welcome LeeAnn as the newest member to our Five Moms campaign,” stated Scott Melville, CHPA president and CEO.  “LeeAnn has dedicated her career to working with stakeholders to educate families about the dangers of medicine and substance abuse among teens. We look forward to partnering with her in our effort to reduce teen medicine abuse nationwide.”
 
Weniger-Mandrillo has a young son, James, and raised her nephew Andrew, who is now 23. She resides in Niskayuna, N.Y., and owns and operates a social marketing firm focused on helping non-profits, coalitions, schools and other parent groups create social media and marketing campaigns about drugs, alcohol, mental health and bullying.
 
CHPA, which represents the leading makers of OTC medicines, launched the Five Moms campaign in 2007 with the goal of driving parents to action — to educate themselves on medicine abuse, to talk with their children about the risks of such abuse, to safeguard medicines in their homes and to spread the word to other parents.
 
In 2009, CHPA introduced an educational icon on the packaging of cough medicines containing DXM to alert parents to the potential for abuse and combined Five Moms and all of its efforts to prevent teen cough medicine abuse into one comprehensive website: StopMedicineAbuse.org. This website provides access to all of the industry’s initiatives and interactive programs to engage parents and community leaders in the fight against teen cough medicine abuse.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Decision Resources Group executive joins Google Healthcare Advisory Board

BY Michael Johnsen

BURLINGTON, Mass. — Decision Resources Group on Wednesday announced that Monique Levy, VP digital innovation at Decision Resources Group, has been selected to join Google's Healthcare Advisory Board. A recognized thought leader, analyst and strategist in the healthcare, media and technology space, Levy will provide key insights on the changing healthcare industry to advance the board's mission.
 
Google established the board in 2013 to help consumers searching for health information make more empowered and informed healthcare decisions. The board's primary mission is to gain a better understanding of the problems that healthcare consumers and providers face and offer feedback on product ideas and development. To accomplish this, Google assembled a group of experts to discuss the changing healthcare landscape and the many issues plaguing the industry.
 
At Decision Resources Group, Levy helps healthcare companies understand and leverage emerging media and technology to improve business performance and customer engagement. She regularly presents cutting-edge research and analysis at industry conferences and is a frequent press contributor, appearing in The Economist, Forbes and Medical Marketing and Media, among other publications.
 
“I'm honored to be part of this distinguished group of industry leaders and work more closely with Google to help drive innovation in healthcare,” Levy said. “Technology — from data, to experiences and devices — will play a central role in the transformation of healthcare to a value, patient-centered and outcomes-driven system.”
 
The board comprises top pharmaceutical, media and agency executives and healthcare thought leaders who are widely regarded as healthcare industry experts. Its activities include hosting a quarterly thought leadership roundtable that helps guide ongoing and upcoming Google health initiatives.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?